Summary
This prediction ended on 27.01.22 with a price of €27.74. The BUY prediction by krebskrebs for Inpixon performed very badly with a performance of -71.11%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Inpixon | - | - | - | - |
| iShares Core DAX® | 1,11 % | 3,98 % | 5,62 % | 49,88 % |
| iShares Nasdaq 100 | 3,27 % | 5,22 % | 41,16 % | 91,99 % |
| iShares Nikkei 225® | 5,78 % | 11,58 % | 64,35 % | 72,79 % |
| iShares S&P 500 | 1,64 % | 2,44 % | 27,36 % | 66,76 % |
Comments by krebskrebs for this prediction
In the thread Inpixon diskutieren
In the thread Trading Inpixon
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten